23andMe's founder Anne Wojcicki wins bid for DNA testing firm-March 2024-www.financetom.com

23andMe's founder Anne Wojcicki wins bid for DNA testing firm

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

23andMe's founder Anne Wojcicki wins bid for DNA testing firm

Jun 13, 2025 1:37 PM

June 13 (Reuters) - Anne Wojcicki is set to regain

control of 23andMe after a nonprofit she controls topped

Regeneron's bid for the DNA-testing company.

(Reporting by Manya Saini and Siddhi Mahatole in Bengaluru;

Editing by Sriraj Kalluvila)

Previous page： Preview: Bkv Corporation Set To IPO Tomorrow Next page： Knightscope Renews Security Robot Contract With Real Estate Firm

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Preview: Bkv Corporation Set To IPO Tomorrow

Sep 26, 2024

BKV Corporation (NYSE:BKV) IPO will take place September, 26 on the NYSE exchange under the ticker BKV. The company is offering shares at an expected price between $19.00 and $21.00 per share with an insider lock-up period of 180 days ending on March 25, 2025. See also: Benzinga IPO Calendar About BKV Corporation BKV Corporation is a forward thinking, growth...

Knightscope Renews Security Robot Contract With Real Estate Firm

Sep 26, 2024

02:00 PM EDT, 09/19/2024 (MT Newswires) -- Knightscope ( KSCP ) said Thursday it has renewed a security robot contract in Texas with a commercial real estate firm, which will deploy one K1 Hemisphere and one K1 Tower to safeguard a large parking facility. Furthermore, Knightscope ( KSCP ) said that a hospital in California has been upgraded to the...

Bioage Labs, Inc IPOs Tomorrow, Here's What You Need To Know

Sep 26, 2024

BioAge Labs, Inc (NASDAQ:BIOA) IPO will take place September, 26 on the NASDAQ exchange under the ticker BIOA. The company is offering shares at an expected price between $17.00 and $19.00 per share with an insider lock-up period of 180 days ending on March 25, 2025. See also: Benzinga IPO Calendar About BioAge Labs, Inc BioAge Labs, Inc is a...

--ATN International Keeps Quarterly Dividend at $0.24 a Share, Payable on Oct. 4 to Shareholders of Record on Sept. 30

Sep 26, 2024

01:56 PM EDT, 09/19/2024 (MT Newswires) -- Price: 29.10, Change: -0.12, Percent Change: -0.41 ...